Empagliflozin Prescribing at STANMORE MEDICAL GROUP
Drugs used in diabetes | Endocrine System
Items (12m)
5,500
Total Quantity
160.4K
NHS Cost
£199.3K
vs National Avg
+778.8%
STANMORE MEDICAL GROUP prescribed 5,500 items of Empagliflozin over the last 12 months at a cost of £199,256 to the NHS. This is 778.8% above the national average prescribing rate. Empagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
449
Jun 2026
467
Jun 2026
479
Jun 2026
485
Jun 2026
415
Jun 2026
517
Jun 2026
468
Jun 2026
466
Jun 2026
495
Jun 2026
410
Jun 2026
448
Jun 2026
401
Prescribing Details
| Total Items | 5,500 |
|---|---|
| Total Quantity | 160,425 |
| Total NHS Cost | £199,256 |
| Presentations | 2 different forms |
| vs National Average | +778.8% |
Empagliflozin Prescribing Comparison
| This practice | 5,500 items |
|---|---|
| National average per practice | 626 items |
| Difference | +778.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.